Table 2.

Cox analysis for disease-free survival in 281 patients with triple-negative breast cancer

Variables	Univariate analysis			Multivariate analysis
	HR	95% CI	P-value	HR	95% CI	P-value
Age (years)
>50 vs ≤50	0.69	0.56–1.09	0.196	0.69	0.51–1.18	0.105
Type of surgery
Radical mastectomy vs breast conserving surgery	1.05	0.91–1.12	0.244	0.92	0.84–1.24	0.379
Tumor stage
T2–4 vs T1	1.69	1.16–2.59	0.006	1.50	1.31–2.49	0.015
Lymphovascular invasion
Yes vs no	1.24	1.09–1.76	0.021	1.01	0.92–1.26	0.152
Histological grade
III vs I–II	2.31	1.92–3.16	<0.001	2.01	1.35–2.59	0.011
Lymph node status
Yes vs no	1.94	1.46–2.38	0.004	1.19	1.16–1.86	0.059
Adjuvant radiotherapy
Yes vs no	0.77	0.69–1.12	0.587	0.72	0.64–1.07	0.659
Chemotherapy
Neoadjuvant vs adjuvant	0.84	0.72–1.15	0.489	0.77	0.69–1.12	0.575
dNLR
≥2.6 vs <2.6	2.39	1.85–2.59	<0.001	1.90	1.52–2.46	0.007

Abbreviation: dNLR, derived neutrophil-to-lymphocyte ratio.